Title:
TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
Document Type and Number:
Japanese Patent JP2022064988
Kind Code:
A
Abstract:
To provide a pharmaceutical composition for treating one or more behavioral symptoms of autism spectrum disorder.SOLUTION: The present invention discloses a pharmaceutical composition for use in a method for treating one or more behavioral symptoms of autism spectrum disorder in a subject, wherein the pharmaceutical composition contains an effective amount of cannabidiol (CBD), and the pharmaceutical composition is formulated for transdermal administration to ensure that one or more behavioral symptoms of autism spectrum disorder are treated in the subject.SELECTED DRAWING: None
Inventors:
MARCEL BONN-MILLER
NANCY TICH
DONNA GUTTERMAN
JOHN MESSENHEIMER
TERRI SEBREE
NANCY TICH
DONNA GUTTERMAN
JOHN MESSENHEIMER
TERRI SEBREE
Application Number:
JP2022015432A
Publication Date:
April 26, 2022
Filing Date:
February 03, 2022
Export Citation:
Assignee:
ZYNERBA PHARMACEUTICALS INC
International Classes:
A61K31/05; A61P25/00
Foreign References:
| WO2016141056A1 | 2016-09-09 |
Other References:
ARCHIVE OF HISTORY FOR NCT02956226, JPN6022013279, June 2017 (2017-06-01), ISSN: 0005036999
EUR. J. PAIN, vol. 20, no. 6, JPN6022013278, July 2016 (2016-07-01), ISSN: 0005037000
EUR. J. PAIN, vol. 20, no. 6, JPN6022013278, July 2016 (2016-07-01), ISSN: 0005037000
Attorney, Agent or Firm:
Kawaguchi International Patent Office